Keyword: Chiesi Farmaceutici
The split gives uniQure full rights to AMT-060 but leaves it without a partner to cofund R&D as it closes in on the start of a pivotal trial.
The key to strengthening the lungs of premature babies may be held by spiders—namely, the way they spin their webs.
Charles River Laboratories has sealed the extension of a previous six-year early drug discovery contract in the field of respiratory disease with Chiesi Farmaceutici.
Aptuit, a CRO focused on early to mid-phase drug development, has inked a deal with Chiesi Farmaceutici to develop new drugs for idiopathic pulmonary fibrosis.
Chiesi Farmaceutici has bought Atopix Therapeutics for its pipeline of asthma treatments.
In its Series A announced today Glycomine, an early-stage biotech working on replacement therapies for rare diseases, raised $12 million with help from Sanderling Ventures and Chiesi Ventures.